Showing results (3341-3350 of 3,354) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|December 2, 2017
Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRobert Hodgson, Matthew Walton, Mousumi Biswas, et al.
Pharmacoeconomics|July 7, 2026
Use and Outcomes of Cost-Effectiveness Analyses and Additional Considerations in Pharmaceutical Reimbursement in the NetherlandsDiederik Brokkelkamp, Vivian Reckers-Droog, Lonneke Timmers, et al.
Pharmacoeconomics|July 6, 2026
SMART Planning of Early-Stage Health Economic Decision Models for Mechanism-Based Precision Treatments in Rare Cancers: An Application and Tool UpdateTeebah Abu-Zahra, Sabine E Grimm, Prashant Changoer, et al.
Pharmacoeconomics|March 9, 2019
Combining the Power of Artificial Intelligence with the Richness of Healthcare Claims Data: Opportunities and ChallengesDavid Thesmar, David Sraer, Lisa Pinheiro, et al.
Pharmacoeconomics|July 8, 2026
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling MethodsThomas S Clemmet, Duc Binh Phan, Alice Copson, et al.
Pharmacoeconomics|July 15, 2026
Inhaled Levodopa for the Management of OFF Episodes in Parkinson's Disease: A Cost-Effectiveness AnalysisDaniel Evans, Chetan Mistry, Harun Knight, et al.
Pharmacoeconomics|July 29, 2026
A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation StudyLisa M Bloudek, Allie B Cichewicz, Kush Patel, et al.
Pharmacoeconomics|July 26, 2026
A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United StatesAidan J McGovern, Frank Cinfio, Roger Luo
Pharmacoeconomics|August 12, 2026
Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey ContinuesJiunn Wang, Baptiste Leurent, Manuel Gomes
Pharmacoeconomics|September 5, 2026
Developing a Quality-of-Life Measure for Carers of People with Dementia for Use in Economic Evaluations: Results from the COCOON ProjectLidia Engel, Briony Dow, Anne Muldowney, et al.
Pageof 336